michael greig, dir. pharma/biopharma americas, bruker daltonics discusses ccs and benefits of tims
Published 3 years ago • 451 plays • Length 3:00Download video MP4
Download video MP3
Similar videos
-
1:35
bruker daltonics the leader in mass spectrometry solutions explaining tims within timstof technology
-
4:04
the power of tims to analyze pesticides in complex matrices
-
3:41
bob galvin, ph.d., vp applied markets for bruker daltonics, introduces the vip-hesi
-
3:05
new ccs-enabled workflows in metaboscape for 4d-lipidomics and 4d-metabolomics
-
3:58
happy international day of light!
-
41:40
mass spectrometry for metaproteomics: corey broeckling
-
1:18:21
etc webinar:past,actual & future directions of trapped ion mobility time of flight mass spectrometry
-
5:21
dia-pasef - ushering in the era of 4d proteomics
-
16:41
#chatswithchaudhrey interviews alice ly, maldi imaging r&d product manager at bruker daltonics
-
7:39
s04e117 #livewithchaudhrey with bruker daltonics (#826) michael easterling at #asms2023 june 5 day 2
-
20:36
addressing the pfas challenge with novel approaches of tims and dart
-
4:35
prof. henning urlaub and dr. christof lenz on the advantage of ion mobility - tims technology
-
36:43
matthias mann symposium: dr. frank laukien - president and ceo bruker corporation
-
2:10
maxis product video
-
25:28
arndt asperger, ph.d., senior applications scientist, bruker daltonics gmbh & co. kg